Your prediction
BiondVax Pharmaceuticals Ltd ADR Stock
BiondVax Pharmaceuticals Ltd ADR dominated the market today, gaining €0.050 (4.420%).
Our community identified positive and negative aspects for BiondVax Pharmaceuticals Ltd ADR stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the BiondVax Pharmaceuticals Ltd ADR stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of BiondVax Pharmaceuticals Ltd ADR in the next few years
Pros
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of BiondVax Pharmaceuticals Ltd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| BiondVax Pharmaceuticals Ltd ADR | 4.420% | -2.586% | -10.317% | -54.435% | -47.196% | - | - |
| Palatin Technologies | -3.950% | -5.682% | -24.112% | -51.199% | -45.079% | -69.634% | -33.520% |
| Alterity Therapeutics Ltd. ADR | -2.500% | -1.626% | -7.634% | - | -12.950% | - | - |
| Immutep Ltd. | -2.230% | 2.926% | -26.486% | -38.739% | -35.238% | 7.368% | 126.667% |
